Journal Logo

​​​​​​​​​​​About the Journal

AIMS & SCOPE

HemaSphere publishes results of highly relevant basic, translational, and clinical research in hematology. We are especially looking for strong studies reporting novel findings that are of high impact to the field of hematology.

Review articles, guideline articles, and controversy articles provide clear overviews and discussions of new developments as well as recommendations for patient care.

HemaSphere is the premier hematology information resource, which is covered by the HemaTopics section in the journal. This section provides insightful discussions on all aspects related to hematology, including summaries of important articles, reports of new therapies, discussions on European policy, and other hematology news items.

HemaSphere is an open access journal, powered by the European Hematology Association, and dedicated to supporting hematology patient care, research, and education worldwide.

INDEXING

HemaSphere is fully indexed in PubMed Central (PMC), in Scopus, and in the following Clarivate Analytics products and categories:

  • SCIENCE CITATION INDEX EXPANDED (SCIE) - Hematology
  • CC/CLINICAL MEDICINE - Hematology
  • Essential Science Indicators - Clinical Medicine

CITATION METRICS & IMPACT FACTOR

HemaSphere is proud to be indexed in Scopus with a CiteScore of 5.4 (April 2022). CiteScore is using a 4-year window to track citations and is updated monthly​.

As a newer journal, HemaSphere does not yet have an Impact Factor, but citations are being tracked and are available in the Web of Science. Clarivate recently completed an evaluation of HemaSphere using the Web of Science selection criteria, and their editors found HemaSphere continues to meet quality criteria and now also meets impact criteria. As such, HemaSphere is expecting its first impact factor in June 2022. 

Journals that are accepted in to SCIE and/or SSCI before January 1st and that remain covered in one of these collections when JCR production is started in March, are eligible to appear in the following June release of the JCR data and receive a Journal Impact Factor™ (JIF), ie, in June 2022.

Coverage will begin with Volume 3, 2019.​

PUBLICATION & EDITORIAL STAFF CONTACTS

Lead Publisher, Open Access
Tarryn Greenberg
[email protected]

Editorial Manager, European Hematology Association
Jessica Mastrodomenico
[email protected]

Production Editor
Tori Kronz
[email protected]​​

Editorial Coordinator ​
hemasphere​@wolterskluwer.com

Marketing Manager
Bob O'Malley
[email protected]

Advertising
For journal specific contacts go to media kit site

Permissions
Go to the article and use the Content & Permissions link under Article Tools

Translations Rights & Licensing
[email protected]
[email protected]

Reprints and Special Projects (U.S./Canada)
For journal specific contacts go tomedia kit site

Reprints and Special Projects (non-U.S./Canada)
[email protected] and for journal specific contacts go to media kit site

Supplements
Tarryn Greenberg, Lead Publisher
Phone: +44 203 197 6707
E-mail: [email protected]

​LWW Business Offices
Citi Building, 41st Floor
25 Canada Square
Canary Wharf
London E14 5LQ
United Kingdom
Tel: +44 (0)20 3197 6500
Fax: +44 (0)20 3197 6501
www.lww.com


EHA Executive Office
Koninginnegracht 12b
2514 AA - The Hague
The Netherlands
Tel: +31 (0)70 3020 099 
[email protected] ​